Bain Capital, LP is one of the world’s leading private multi-asset alternative investment firms with approximately $130 billion of assets under management that creates lasting impact for our investors, teams, businesses, and the communities in which we live. Since our founding in 1984, we’ve applied our insight and experience to organically expand into several asset classes including private equity, credit, public equity, venture capital and real estate. We leverage our shared platform to capture cross-asset class opportunities in strategic areas of focus. With offices on four continents, our global team aligns our interests with those of our investors for lasting impact.

Bain Capital Investor Portal Please log in to access your account information. If you have any questions regarding your account, please contact [email protected].

Bain Capital and Cinven announce Marc Doyle as future CEO of Lonza Specialty Ingredients

May 26, 2021

Media Contacts

Share this page

Bain Capital and Cinven announce Marc Doyle as future CEO of Lonza Specialty Ingredients

Basel, May 26, 2021- Bain Capital and Cinven announced today their intention to appoint Marc Doyle as CEO of Lonza Specialty Ingredients (‘LSI’), immediately upon completion of the acquisition of LSI from Lonza AG, which is expected to occur early in the second half of 2021. 

Marc is a highly experienced executive in the chemicals industry, with many years of experience of managing global specialty chemicals businesses. He was previously CEO of DuPont, one of the world’s largest chemicals groups, and before that COO of DuPont’s Specialty Products Division, where he ran an extensive portfolio across multiple end-markets and achieved strong growth across those business units.

Marc joined DuPont as a research engineer and subsequently held various positions across new business development, marketing, strategy, and management.  Marc has a PhD in Chemical Engineering from the University of California at Berkeley, and BSc in Chemical Engineering from the University of Virginia.

Marc will relocate to the future headquarters of LSI in Basel, Switzerland. 

Marc Doyle commented: “I am excited to join LSI and to take over the CEO role once the transaction is completed. LSI is a very strong specialty chemicals business, as a global leader in its markets, and with enormous potential as an independent company under new ownership. I am looking forward to working closely with Bain Capital and Cinven, and with all of the LSI team, to deliver on that opportunity in the months and years ahead”.

Pontus Pettersson, Partner at Cinven, added: “We are very pleased that a CEO of Marc’s calibre and depth of experience will join LSI; his expertise from across the specialty chemicals industry will add great value to LSI as we jointly prosecute our growth strategy for the company.”

David Danon, Managing Director at Bain Capital, said: “Marc is a world-class leader in specialty chemicals who will be instrumental in leading LSI to achieve its full potential, by reinforcing its market position, accelerating growth through investments in innovation, and leading further industry consolidation.”

Bain Capital and Cinven entered into definitive transaction agreements with Lonza AG for the acquisition of Lonza Specialty Ingredients in February 2021. The transaction remains subject to customary closing conditions, and is expected to complete over the course of summer 2021. 

Bain Capital and Cinven’s strategy for LSI is to strengthen the company’s market position across both Microbial Control Solutions (MCS) and Specialty Chemical Services (SCS), to accelerate growth including through further investment in R&D, and to use LSI as a platform for further M&A. Bain Capital and Cinven are committed to growing their businesses responsibly, and recognise the importance of the environmental, regulatory and local stakeholder responsibilities of LSI. They also intend to maintain the strong collaboration between LSI and Lonza AG until completion and afterwards.  

About Bain Capital Private Equity 
Bain Capital Private Equity has partnered closely with management teams to provide the strategic resources that build great companies and help them thrive since its founding in 1984. Bain Capital Private Equity’s global team of approximately 240 investment professionals creates value for its portfolio companies through its global platform and depth of expertise in key vertical industries including healthcare, consumer/retail, financial and business services, industrials, and technology, media and telecommunications. Bain Capital has 19 offices on four continents. The firm has made primary or add-on investments in more than 760 companies since its inception. In addition to private equity, Bain Capital invests across asset classes including credit, public equity and venture capital, managing approximately $120 billion in total and leveraging the firm’s shared platform to capture opportunities in strategic areas of focus.

For more information, visit www.baincapital.com

About Cinven
Cinven is a leading international private equity firm focused on building world-class global companies. Its funds invest in six key sectors: Business Services, Consumer, Financial Services, Healthcare, Industrials and Technology, Media and Telecommunications (TMT). Cinven has offices in London, New York, Frankfurt, Paris, Milan, Madrid, Guernsey and Luxembourg. 
Cinven takes a responsible approach towards its portfolio companies, their employees, suppliers, local communities, the environment and society. 

For more information on Cinven, visit www.cinven.com